Identification of CTX-M Gene Resistance on Bacteria Acinetobacter baumannii and Klebsiella pneumoniae in Pneumonia Patients in Haji Adam Malik Center Hospital, Medan, Indonesia

  • Safrina S Department of Pharmaceutical Pharmacology, Universitas Sumatera Utara
  • Urip Harahap Department of Pharmaceutical Pharmacology, Universitas Sumatera Utara
  • Fransiscus Ginting Department of Medicine, Haji Adam Malik Center Hospital
DOI https://doi.org/10.22270/ajprd.v8i1.640

Abstract

Objectives: To find out whether Acinetobacter baumannii and Klebsiella pneumoniae that cause pneumonia have Ceftriaxon-resistant CTX-M coding genes.


Interventions: The method used in this study is a cross sectional prospective design and carried out prospectively in pneumonia patients who have medical record data on the diagnosis of pneumonia patients in the period January to September 2019 at the Haji Adam Malik General Hospital in Medan by taking sputum from the patient, then detected using Polymerase Chain Reaction (PCR) in the Integrated Laboratory of the Faculty of Medicine, Universitas Sumatra Utara.


Main outcomes measure: The resistance coding gene in Klebsiella pneumoniae with the percentage of CTX-M gene is 93.7% and Acinetobacter baumannii has a low percentage where the expression of CTX-M gene is 17.6%.


Conclusion: The distribution of the CTX-M gene in Klebsiella Pneumoniae is higher than that of Acinetobacter baumannii.


 

Keywords: CTX-M gene, Acinetobacter baumannii, Klebsiella pneumoniae, pneumonia

Downloads

Download data is not yet available.

Author Biographies

Safrina S, Department of Pharmaceutical Pharmacology, Universitas Sumatera Utara

Department of Pharmaceutical Pharmacology, Universitas Sumatera Utara

Urip Harahap, Department of Pharmaceutical Pharmacology, Universitas Sumatera Utara

Department of Pharmaceutical Pharmacology, Universitas Sumatera Utara

Fransiscus Ginting, Department of Medicine, Haji Adam Malik Center Hospital

Department of Medicine, Haji Adam Malik Center Hospital

References

1. Champoux J, Drew WL, Neidhardt FC, and Plorde JJ. Sherris Medical Microbiology: An Introduction to Infectious Diseases. 4th ed. United States of America: Mc.Graw Hill.Clinical and Laboratory Standard Institute; 2004.
2. Gassem, HM and S Setiawan. Profil klinik dan laboratorium pasien Community acquired Pneumonia sembuh dan meninggal di RSUP Dokter kardi. Jakarta: Media MedikaMuda; 2015.
3. Riyahi, ZF, et al. The Prevalence of TEM and SHV Genes among Extended- Spectrum Beta- Lactamases Producing Escheria coli and Kleibseilla pneumoniae. Iranian Journal of Basic Medical Sciences. 2012; 15(1): 654-660.
4. Tuon FF, Kruger M, Terreri M, Penteado-Filho SR, Gortz L. Klebsiella ESBL Bacteremia Mortality and risk factors. Braz J Infect Dis. 2011; 15(6): 594-8.
5. Devinna K, Rano KS, T Rostianawati, R Abdullah. Gene blaCTX-M Mutation as Risk Factor of Antibiotic Resistance. Indonesian Journal of Clinical Pharmacy. 2017; 6(2):135-152.
6. Prasetya, YA. Identifikasi Gen Ctx-M pada Esherichia coli Penghasil Extended Spectrum Beta-Lactamases (ESBLs) di RSUD Dr. Soetomo Surabaya. Jurnal Teknologi Laboratorium. 2017; 6(2):56-60.
7. Notoatmodjo, S. (2011).Kesehatan Masyarakat Ilmu dan Seni. Jakarta: Penerbit Rineka Cipta. p 45.
8. Lisdawati, V., I Parwati, Sudarmon, TM., Sudiro, R., R. Ramadhany., N. Puspandari., et al. Studi Pemetaan Awal DNA Mycobacterium tuberculosis complex Secara Spoligo typing Pada Hasil Isolasi Dahak Pasien Tuberkulosis Paru dari 10 Kota Propinsi. Buletin Penelitian Kesehatan. 2010; 38(4):169-185
9. Rubstova MY, Ulyashova MM, Bachmann TT, Schmid RD, Egorov AM. Multiparametric Determination Of Genes And Their Point Mutations For Identification Of Betalactamase. Biochemistry. 2010; 75(13):1628-49.
10. Hout B. et al. Drug resistance in bacteria Isolated from Patients Presenting with Wounds At A Nonprofit Surgical Center in Phnom Penh, Cambodia from 2011–2013. Tropical Diseases Travel Medicine and Vaccines. 2015; 1(4).
11. Murakami K., W Minamide, K Wada, E Nakamura, H Teraoka, S Watanabe. Identification of Methicillin-Reistant Strains of Staphylococci by Poymerase Chain Reaction. Journal of Clinical Microbiology. 1991; 2(10):2240-2244.
12. Kaczmarek, FM,. F Dibb-Hajj, W Shang, TD Gootz. High Level Carbapenem Resistance in Klebsiella pneumoniae Clinical Isolate is Due to the Combination of blaACT-1β-Lactamase Production, Porin OmpK35/36 Insertional Inactivation, and Down-Regulation of the Phosphate Transport Porin PhoE. Antimicrobial Agent and Chemotherapy. 2006; 50(10):3396-3406.
13. Shin SY, IK Bae, J Kim, SH Jeong, D Yong, JM Kim, K Lee. Resistance to Cabapenems in Sequence Type 11 Klebsiella pneumoniae is Relates to DHA-1 and Loss of OmpK35 and/or OmpK36. Journal of Medical Microbiology. 2012; 61(2):239-245.
14. Palasubramaniam S, S Muniandy, P Navartnam. Resistance to Extended-Spectrum β-Lactams by the Emergence of SHV-12 and the Loss of OmpK35 in Klebsiella pneumoniae and Escherichia coli in Malaysia. J Microbiol Immunol Infect. 2009; 42:129-133.
15. Paterson DL, RA Bonomo. Extended-Spectrum β-Lactamases: a Clinical Update. Clinical Microbiology Journal. 2005; 18(4):658-686.
Statistics
613 Views | 661 Downloads
How to Cite
S, S., Harahap, U., & Ginting, F. (2020). Identification of CTX-M Gene Resistance on Bacteria Acinetobacter baumannii and Klebsiella pneumoniae in Pneumonia Patients in Haji Adam Malik Center Hospital, Medan, Indonesia. Asian Journal of Pharmaceutical Research and Development, 8(1), 25-28. https://doi.org/https://doi.org/10.22270/ajprd.v8i1.640
Issue
Vol 8 No 1 (2020): Vol 8 No 1 (2020): Volume 8 Issue 1 Jan - Feb. 2020
Section
Research Articles
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:

Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.

Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.

Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).